We are inviting your child to take part in a research study, investigating if an already-approved oral medication to treat ADHD in children over the age of 6 is also effective in treating children under the age of 6.
The Children’s ADHD Study will enroll about 130 participants between the ages of 4 years old to 5 years and 10 months old. The study will include 6 visits to a study center. This study involves having your child take the study medication once daily for the duration of the study, about one month.
There is no cost to take part in the Children’s ADHD Study. In addition, participants will receive up to $300 for participation. No health insurance is required.
Your child may qualify for the Children’s ADHD Study if they:
- Are between the ages of 4 years old to 5 years and 10 months old
- Have a diagnosis of ADHD or exhibit symptoms of ADHD, such as:
- Inability to sit still
- Constantly fidgeting
- Excessive movements and/or talking
- Inability to concentrate
- Unable to wait their turn
All study-related care, including the study medicine. Those who take part in the study will receive compensation up to $300.
There is no cost to participate in the study. In addition participants will receive up to $300.
Sign Up
What happens if I sign up? We will match your child to a research study location in your area that needs volunteers with ADHD or notify you when one becomes available. The study team will then contact you and your child may have the opportunity to participate if qualified.
If you think you might like to have your child participate in the Children’s ADHD Study or would like more information, please enter their information below so we can see if they may qualify and can contact you about the study. Keep in mind that participation is entirely voluntary. If you do decide to take part in a study, you may change your mind about participating at any time.
About ADHD
ADHD is a common neurobehavioral disorder that occurs in 6% to 8% of children worldwide and often starts in childhood.1,2 For many people, ADHD can be mistaken as bad behavior, instead of a medical condition.2 Without the right diagnosis and treatment options early on, ADHD can make school, relationships, and work much harder for your child.
The 3 main symptoms of ADHD include inattention, hyperactivity, and impulsivity.3 Other symptoms may include:3
- Inability to sit still
- Constantly fidgeting
- Excessive movements and/or talking
- Inability to concentrate
- Unable to wait their turn
The most common and effective medicines for the treatment of ADHD are central nervous system (CNS) stimulants, which contain amphetamine or methylphenidate (MPH).4 Several studies have shown that, in children with ADHD, MPH improves classroom functioning, notably by decreasing disruptive behavior and increasing academic productivity, accuracy and improvement in teacher ratings. In addition, MPH has been shown to improve performance in children for several cognitive tasks, including measures of attention and memory.4
The Children’s ADHD Study is researching if an already FDA-approved medication to treat ADHD in children over the age of 6 is also effective in treating children under the age of 6.
Frequently Asked Questions
What is a research study?
A research study (also called a clinical trial) is a medical study that helps to answer important questions about an investigational drug – these may include how well an investigational study drug works for a certain condition. All medications must be tested in clinical research studies before they can be approved and prescribed to patients.
Why are research studies important?
A research study is the process by which new and innovative medications, interventions and treatments are approved and brought to market, so people can live happier and healthier lives. Even over-the-counter medications, such as NSAIDs (e.g., Tylenol, Advil), you may have used to counteract a headache, have gone through the clinical research study process before it was available at your local pharmacy.
What is the purpose of the Children’s ADHD Study?
The Children’s ADHD Study is researching if an already-approved medication to treat ADHD in children over the age of 6 is also effective in treating children under the age of 6.
What will the Children’s ADHD Study involve?
The Children’s ADHD Study will enroll about 130 participants between the ages of 4 years old to 5 years and 10 months old with ADHD at approximately 21 study centers throughout the United States. The study will include approximately 6 visits to a study center in your location over the duration of the study, about 30-45 days.
If your child successfully completes the study, they will be given an opportunity to participate in a long-term safety study (i.e., all subjects receive active medication at no cost - Azstarys® for 12 months)
Will I receive compensation?
Volunteers who qualify to take part in the study will receive compensation up to $300. Please discuss this with the study team when they contact you.
Is there a cost to participate?
There is no cost to participate in the Pediatric Functional Constipation Studies. If your child qualifies, they will receive all study-related care from a team of trained medical professionals at no cost.
What else do I need to consider?
The research team will be able to explain more about what the Children’s ADHD Study will involve, and it is up to you to decide if you want to take part. Participation in this study is voluntary. Whether or not you decide to participate in this study will not affect your current or future relationships with your doctors. If you decide to participate, you are free to withdraw at any time without affecting those relationships.
How far is the study center?
We match your child to a study center within a close travel distance from your home. If we are not running the study in your area currently, with your permission, we will keep you and your child’s information in our database and reach out once a study in your area becomes available. If, at any time, you decide you no longer want your information stored, you can opt out and we will delete your details.
About the Children’s ADHD Study
The Children’s ADHD Study will enroll about 130 participants between the ages of 4 years old to 5 years and 10 months old with ADHD at approximately 21 study centers throughout the United States. The study will include approximately 6 visits to a study center in your area over the duration of the study, about 30-45 days.
Participants will be paid up to $300 for participation in the study. Insurance is not required to participate. All study-related care, including the study medicine is provided at no cost.
If your child successfully completes the study, they will be given an opportunity to participate in a long-term safety study (i.e., all subjects receive active medication at no cost - Azstarys® for 12 months)
Who can take part in the Children’s ADHD Study?
Your child may qualify for the Children’s ADHD Study if they:
- Are between the ages of 4 years old to 5 years and 10 months old
- Have a diagnosis of ADHD or exhibit symptoms of ADHD, such as:
- Inability to sit still
- Constantly fidgeting
- Excessive movements and/or talking
- Inability to concentrate
- Unable to wait their turn
The Children’s ADHD Study is researching if an already FDA-approved medication to treat ADHD in children over the age of 6 is also effective in treating children under the age of 6.